Inspira Technologies Oxy B.H.N. Ltd. is an innovative medical technology company focused on enhancing respiratory support for critically ill patients through its proprietary advanced oxygen delivery systems. The firm's commitment to improving patient outcomes positions it strategically within the rapidly growing medical device sector, driven by an increasing global demand for effective respiratory therapies. With its pioneering solutions, Inspira aims to transform critical care and meet the evolving challenges of the healthcare market, making it a compelling prospect for institutional investors interested in the future of healthcare advancements.
| Revenue (TTM) | 289,000 |
| Gross Profit (TTM) | 2,000 |
| EBITDA | $-13.47M |
| Operating Margin | -4714.00% |
| Return on Equity | -397.90% |
| Return on Assets | -127.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.07 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $36.51M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |